Author:Julie Reid

Real World Evidence in Cancer report image

Thought Leadership

Cancer

The role of real-world evidence in reducing clinical uncertainty in cancer treatment
Navigating Expanded Access Programs in Europe

Thought Leadership

Rare diseases

Navigating early access in Europe: a strategic blueprint for biotech leaders
fallback image

Blogs

Our digital support pilot is showing early signs of success in improving patient health outcomes
rare and orphan diseases

Blogs

Rare diseases

Early access programs – benefits, challenges and the Sciensus solution
Thought leadership - strategies for entering european market

Thought Leadership

Rare diseases

Strategies for entering the European orphan drugs market 
Sciensus_Fierce Biotech_white paper_final

Thought Leadership

Rare diseases

Realise your European orphan drug expansion
orphan drug distribution

Thought Leadership

Rare diseases

Take the risk out of your orphan drug distribution in Europe
Navigating regulatory challenges in the EU

Thought Leadership

Rare diseases

EU orphan drug roll out: navigating regulatory challenges
Integrating clinical studies and Patient Support Programs- Sciensus

Thought Leadership

Rare diseases

Integrating clinical studies and Patient Support Programs(PSPs) for holistic rare disease care